FATE – Fate Therapeutics, Inc.
Fate Therapeutics, Inc.FATE
$1.39Name : Fate Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $160,308,272.00
EPSttm : -1.46
Fate Therapeutics, Inc.
$1.39
1.42%$0.02Float Short %
9.02
Margin Of Safety %
Put/Call OI Ratio
0.09
EPS Next Q Diff
0.04
EPS Last/This Y
0.54
EPS This/Next Y
0.03
Price
1.38
Target Price
4.45
Analyst Recom
2.25
Performance Q
20.87
Relative Volume
1.49
Beta
2.42
Ticker: FATE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-09-08 | FATE | 0.9661 | 0.18 | 1.03 | 3503 |
| 2025-09-09 | FATE | 0.9785 | 0.18 | 0.00 | 3533 |
| 2025-09-10 | FATE | 1 | 0.18 | 0.00 | 3539 |
| 2025-09-11 | FATE | 1.015 | 0.17 | 1.30 | 3611 |
| 2025-09-12 | FATE | 0.9621 | 0.18 | 3.29 | 3661 |
| 2025-09-15 | FATE | 0.9503 | 0.18 | 5.00 | 3677 |
| 2025-09-16 | FATE | 0.9478 | 0.19 | 0.01 | 3688 |
| 2025-09-17 | FATE | 0.95 | 0.1825 | 0.96590909090909 | 3784 |
| 2025-09-18 | FATE | 0.9845 | 0.18 | 0.00 | 3800 |
| 2025-09-22 | FATE | 1.01 | 0.11 | 0.21 | 3680 |
| 2025-09-23 | FATE | 0.9689 | 0.12 | 0.06 | 4013 |
| 2025-09-24 | FATE | 1 | 0.12 | 0.00 | 4045 |
| 2025-09-25 | FATE | 0.9785 | 0.12 | 0.00 | 4096 |
| 2025-09-26 | FATE | 0.9935 | 0.11 | 0.03 | 4210 |
| 2025-09-29 | FATE | 1 | 0.11 | 0.01 | 4213 |
| 2025-09-30 | FATE | 1.26 | 0.11 | 0.09 | 4376 |
| 2025-10-01 | FATE | 1.25 | 0.09 | 0.01 | 5250 |
| 2025-10-02 | FATE | 1.2 | 0.09 | 0.23 | 5456 |
| 2025-10-03 | FATE | 1.21 | 0.09 | 0.33 | 5474 |
| 2025-10-06 | FATE | 1.42 | 0.09 | 0.20 | 5478 |
| 2025-10-07 | FATE | 1.39 | 0.09 | 0.09 | 6075 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-09-08 | FATE | 0.97 | 31.2 | - | -1.08 |
| 2025-09-09 | FATE | 0.98 | 31.2 | - | -1.08 |
| 2025-09-10 | FATE | 1.00 | 31.2 | - | -1.08 |
| 2025-09-11 | FATE | 1.02 | 31.2 | - | -1.08 |
| 2025-09-12 | FATE | 0.96 | 31.2 | - | -1.08 |
| 2025-09-15 | FATE | 0.95 | 31.2 | - | -1.08 |
| 2025-09-16 | FATE | 0.95 | 31.2 | - | -1.08 |
| 2025-09-17 | FATE | 0.95 | 31.2 | - | -1.08 |
| 2025-09-18 | FATE | 0.99 | 31.2 | - | -1.08 |
| 2025-09-19 | FATE | 0.95 | 31.2 | - | -1.08 |
| 2025-09-22 | FATE | 1.01 | 29.9 | - | -1.10 |
| 2025-09-23 | FATE | 0.97 | 29.9 | - | -1.10 |
| 2025-09-24 | FATE | 1.00 | 29.9 | - | -1.10 |
| 2025-09-25 | FATE | 0.97 | 29.9 | - | -1.10 |
| 2025-09-26 | FATE | 1.00 | 29.9 | - | -1.10 |
| 2025-09-29 | FATE | 1.00 | 29.9 | - | -1.10 |
| 2025-09-30 | FATE | 1.26 | 29.9 | - | -1.10 |
| 2025-10-01 | FATE | 1.25 | 29.9 | - | -1.10 |
| 2025-10-02 | FATE | 1.20 | 29.9 | - | -1.10 |
| 2025-10-03 | FATE | 1.21 | 29.9 | - | -1.10 |
| 2025-10-06 | FATE | 1.43 | 29.9 | - | -1.10 |
| 2025-10-07 | FATE | 1.38 | 29.9 | - | -1.10 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-09-08 | FATE | -0.40 | -20.24 | 8.59 |
| 2025-09-09 | FATE | -0.40 | -20.24 | 8.59 |
| 2025-09-10 | FATE | -0.40 | -20.24 | 8.59 |
| 2025-09-11 | FATE | -0.40 | -20.24 | 8.82 |
| 2025-09-12 | FATE | -0.40 | -20.24 | 8.82 |
| 2025-09-15 | FATE | -0.40 | -20.05 | 8.82 |
| 2025-09-16 | FATE | -0.40 | -20.05 | 8.82 |
| 2025-09-17 | FATE | -0.40 | -20.05 | 8.82 |
| 2025-09-18 | FATE | -0.40 | -20.05 | 8.82 |
| 2025-09-19 | FATE | -0.40 | -20.05 | 8.82 |
| 2025-09-22 | FATE | -0.40 | -20.06 | 8.82 |
| 2025-09-23 | FATE | -0.40 | -20.06 | 8.82 |
| 2025-09-24 | FATE | -0.40 | -20.06 | 8.82 |
| 2025-09-25 | FATE | -0.40 | -20.06 | 9.02 |
| 2025-09-26 | FATE | -0.40 | -20.06 | 9.02 |
| 2025-09-29 | FATE | -0.40 | -20.06 | 9.02 |
| 2025-09-30 | FATE | -0.40 | -20.06 | 9.02 |
| 2025-10-01 | FATE | -0.40 | -20.06 | 9.02 |
| 2025-10-02 | FATE | -0.40 | -20.06 | 9.02 |
| 2025-10-03 | FATE | -0.40 | -20.06 | 9.02 |
| 2025-10-06 | FATE | -0.40 | -13.01 | 9.02 |
| 2025-10-07 | FATE | -0.40 | -13.01 | 9.02 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.29
Avg. EPS Est. Current Quarter
-0.28
Avg. EPS Est. Next Quarter
-0.25
Insider Transactions
-0.4
Institutional Transactions
-13.01
Beta
2.42
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
14
Growth Score
24
Sentiment Score
53
Actual DrawDown %
98.9
Max Drawdown 5-Year %
-99.4
Target Price
4.45
P/E
Forward P/E
PEG
P/S
18.93
P/B
0.61
P/Free Cash Flow
EPS
-1.45
Average EPS Est. Cur. Y
-1.1
EPS Next Y. (Est.)
-1.07
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-2025.05
Relative Volume
1.49
Return on Equity vs Sector %
-90.8
Return on Equity vs Industry %
-77.1
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
Fate Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 181
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
stock quote shares FATE – Fate Therapeutics, Inc. Stock Price stock today
news today FATE – Fate Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FATE – Fate Therapeutics, Inc. yahoo finance google finance
stock history FATE – Fate Therapeutics, Inc. invest stock market
stock prices FATE premarket after hours
ticker FATE fair value insiders trading